Bio-Techne Corporation

Doing business as Bio-Techne Bio-Techne Corporation

UEI
RDJKATCM39L5
CAGE
88F99
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
bio-techne.com
Founded
1976
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Bio-Techne Corporation's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Fetal bovine serum Contract · 75F40119P10387 Food and Drug Administration $0

About Bio-Techne Corporation

Written by GovTribe AI ·

Bio-Techne Corporation, doing business as Bio-Techne and its subsidiaries, is a leading provider of life sciences tools and bioactive reagents for the research, diagnostic, and bioprocessing markets. The company offers a diverse portfolio of products including proteins, antibodies, immunoassays, small molecules, and other specialized reagents and instruments. Bio-Techne has been awarded numerous federal contracts and grants to support biomedical research, drug development, and healthcare initiatives across various government agencies. The company's expertise in protein analysis, cell biology, and molecular diagnostics has positioned it as a valuable partner for federal research programs and clinical applications.

Through federal contract awards, Bio-Techne and its subsidiaries have supplied a wide range of specialized research tools and services to agencies such as the National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense (DoD). These contracts have included the provision of automated protein analysis systems like the Jess and Wes platforms from ProteinSimple, RNAscope in situ hybridization assays from Advanced Cell Diagnostics, and custom recombinant proteins and antibodies from R&D Systems. The company has also delivered Luminex-based multiplex assays, ELISA kits, and other immunoassay products to support COVID-19 research, cancer studies, and infectious disease investigations. Many of these awards have been small business set-asides, reflecting the specialized nature of Bio-Techne's offerings. The primary funding agencies have been various NIH institutes, with significant contracts also coming from the VA and DoD for research equipment and diagnostic services.

While the provided information does not detail specific federal grant awards to Bio-Techne, the company's products and services are widely used in grant-funded research projects across academic and government laboratories. Bio-Techne's reagents, assays, and instruments support a broad spectrum of life sciences research, including studies in cancer biology, immunology, neuroscience, and stem cell research. It is likely that numerous NIH-funded grants utilize Bio-Techne's products as essential research tools, even if the company is not directly named as a grant recipient. The company's contributions to grant-funded research are primarily through the provision of critical reagents and technologies that enable scientific discoveries and advancements in biomedical research.

Bio-Techne holds a position on the Medical Laboratory Testing and Analysis Services (FSS-621-II) GSA Schedule, which allows government agencies to easily procure its diagnostic services, particularly through its Exosome Diagnostics subsidiary. This indefinite delivery vehicle (IDV) facilitates the ordering of specialized laboratory testing services by various federal healthcare providers, including VA medical centers. While specific task order details are limited in the provided information, this contract vehicle positions Bio-Techne to support a range of clinical diagnostic needs across government healthcare systems. The company's presence on this schedule demonstrates its capability to deliver advanced molecular diagnostic services to federal agencies, complementing its broader portfolio of research and clinical products.

Quick answers

What is Bio-Techne Corporation's UEI?

Bio-Techne Corporation's Unique Entity ID (UEI) in SAM.gov is RDJKATCM39L5.

What is Bio-Techne Corporation's CAGE code?

Bio-Techne Corporation's CAGE code is 88F99.

What is Bio-Techne Corporation's primary NAICS code?

Bio-Techne Corporation's primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Is Bio-Techne Corporation registered in SAM.gov?

Bio-Techne Corporation's SAM.gov registration expired on January 29, 2020.

What is Bio-Techne Corporation's most recent federal award?

Bio-Techne Corporation's most recent federal contract award is Fetal bovine serum (75F40119P10387), from Food and Drug Administration, on August 1, 2019.

On GovTribe

See Bio-Techne Corporation's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login